Nanolive

First microscope for automated live cell imaging.

Nanolive delivers breakthrough imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. Nanolive’s innovative solutions combine screening, imaging and analysis to radically advance how scientists study living cells and provide novel biological insights such as the mechanisms of cancer and neurodegenerative diseases.Nanolive imaging platforms allow scientists to explore living cells in 3D without damaging them. By delivering complete measurements and understandings on a sub-cellular scale (e.g. mitochondrial networks, stem cell differentiation),.Nanolive technology allows screening across thousands of live cell populations, and potential therapeutic use of those same, unperturbed, cells.

See company profile



2334

In viverra donec faucibus magna odio auctor. In id sed nec, hendrerit facilisi. Ut interdum ut sit justo mauris diam.

345

Laboratories integrated into the core the EPFL Innovation Park consectetur adipiscing elit. Ornare consequat, eget eget urna enim urna, sit maecenas in.

27

mio

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vel ipsum, proin ut pellentesque at lacus, egestas. Dolor odio ultricies curabitur nisl, nibh. Imperdiet rhoncus felis.

The Tech4Eva accelerator program started with the opening ceremony on Wednesday 17.04.2021. 30 start-ups and projects from all over the world were selected, among them 11 from Switzerland.

‍

Tech4Eva, the first FemTech accelerator in Switzerland, is a joint endeavor of EPFL Innovation Park and Groupe Mutuel. The equity-free program has the ambition to accelerate the growth of promising Femtech start-ups, and to create an innovation platform in Switzerland, where disruptive start-ups and projects from around the globe can meet and develop innovative solutions for improving or advancing technologies relating to women’s health.

It also aims to create a global FemTech community by connecting all stakeholders active in the sector.

The inaugural program received over 110 early and growth stage start-ups applications from 25 countries around the globe 70 or 65% of which are led by women founders. 15 growth stage start-ups and 15 early stage companies and projects entered the nine-month program. The start-ups are coming from Switzerland, France, UK, Germany, Israel, the USA and five further countries including Singapore.

A good third is active in the sector fertility and pregnancy followed by women’s wellness and women’s medicine. Most of the companies (14) are developing therapies.

Tech4Eva’s 9-month acceleration program consists of multi-layer activities, such as mentorship by corporate experts, specialized workshops, roadshows, peer-to-peer experience, training curriculum as well as focus groups in different areas of FemTech.

Highlights of the program for the growth stage start-ups include workshops, introduction to potential business partners, investor pitch sessions and virtual road shows to Japan, London and Boston.

All teams and projects can be found on the Tech4Eva website. Eleven teams from Switzerland were chosen:

See company profile



© EPFL Innovation Park | Developed by Coteries